LeMaitre Vascular, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5255582018
USD
92.25
0.3 (0.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Veracyte, Inc.
STAAR Surgical Co.
LeMaitre Vascular, Inc.
Tandem Diabetes Care, Inc.
TransMedics Group, Inc.
Pacific Biosciences of California, Inc.
PROCEPT BioRobotics Corp.
NovoCure Ltd.
Alphatec Holdings, Inc.
Myriad Genetics, Inc.
Owens & Minor, Inc.

Why is LeMaitre Vascular, Inc. ?

1
The company is Net-Debt Free
2
Low Debt Company with Strong Long Term Fundamental Strength
3
Positive results in Mar 26
  • OPERATING CASH FLOW(Y) Highest at USD 87.3 MM
  • ROCE(HY) Highest at 16.55%
  • DEBT-EQUITY RATIO (HY) Lowest at -43.63 %
4
With ROE of 14.67%, it has a attractive valuation with a 6.59 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 10.28%, its profits have risen by 30.9% ; the PEG ratio of the company is 1.5
5
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Underperformed the market in the last 1 year
  • The stock has generated a return of 10.28% in the last 1 year, much lower than market (S&P 500) returns of 22.24%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to LeMaitre Vascular, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is LeMaitre Vascular, Inc. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
LeMaitre Vascular, Inc.
8.79%
0.49
37.81%
S&P 500
20.78%
1.67
13.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
14.05%
EBIT Growth (5y)
18.37%
EBIT to Interest (avg)
29.28
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
0.54
Tax Ratio
22.56%
Dividend Payout Ratio
31.77%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
19.44%
ROE (avg)
11.36%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
45
Industry P/E
Price to Book Value
6.59
EV to EBIT
35.43
EV to EBITDA
30.72
EV to Capital Employed
11.68
EV to Sales
9.64
PEG Ratio
1.51
Dividend Yield
72.97%
ROCE (Latest)
32.97%
ROE (Latest)
14.67%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 87.3 MM

ROCE(HY)

Highest at 16.55%

DEBT-EQUITY RATIO (HY)

Lowest at -43.63 %

DIVIDEND PER SHARE(HY)

Highest at USD 7.23

RAW MATERIAL COST(Y)

Fallen by -5.74% (YoY

NET PROFIT(9M)

Higher at USD 48.62 MM

CASH AND EQV(HY)

Highest at USD 726.35 MM

NET SALES(Q)

Highest at USD 66.55 MM

-7What is not working for the Company
INTEREST(HY)

At USD 2.6 MM has Grown at 73.78%

Here's what is working for LeMaitre Vascular, Inc.

Operating Cash Flow
Highest at USD 87.3 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at -43.63 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Dividend per share
Highest at USD 7.23 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (USD)

Net Profit
At USD 48.62 MM has Grown at 45.63%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Net Sales
Highest at USD 66.55 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Cash and Eqv
Highest at USD 726.35 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Net Profit
Higher at USD 48.62 MM
than preceding 12 month period ended Mar 2026
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (USD MM)

Raw Material Cost
Fallen by -5.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for LeMaitre Vascular, Inc.

Interest
At USD 2.6 MM has Grown at 73.78%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)